Skip to main content

Inception: David Weild IV

  • Chapter
  • First Online:
  • 303 Accesses

Abstract

David Weild IV is a scientist by training. He started his career as an academic biologist who really didn’t like biology but who liked genetics, fulfilling most of his undergraduate requirements with graduate course work in molecular genetics. He left graduate programs, ultimately finding himself on Wall Street, and was fascinated when watching Genentech go public (1980): seeing the stock open at $35 per share and cresting within an hour at more than $88.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   29.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   37.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Adam Gower .

Rights and permissions

Reprints and permissions

Copyright information

© 2018 The Author(s)

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Gower, A. (2018). Inception: David Weild IV. In: Leaders of the Crowd. Palgrave Macmillan, Cham. https://doi.org/10.1007/978-3-030-00383-8_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-00383-8_2

  • Published:

  • Publisher Name: Palgrave Macmillan, Cham

  • Print ISBN: 978-3-030-00382-1

  • Online ISBN: 978-3-030-00383-8

  • eBook Packages: Economics and FinanceEconomics and Finance (R0)

Publish with us

Policies and ethics